Source: The Guardian [UK]
“The first pill version of the blockbuster GLP-1 weight loss drugs has been launched in the US by Novo Nordisk at a lower cost than jab varieties, accelerating a price war in the sector. The Danish pharmaceutical company said on Monday that its once-a-day Wegovy pill, which received approval from the US regulator just before Christmas, was now available in the country. … the highest doses cost $299 a month. Patients with insurance pay from $25 a month. Matt Weston, a pharmaceutical analyst at UBS, said the price was lower than expected. US list prices for weight-loss jabs are about $1,000 a month or more, although Novo Nordisk started selling its Wegovy injection at $349 a month to cash payers in November.” (01/05/26)